Dx & Vx Co., Ltd. (KOSDAQ:180400)
4,725.00
+120.00 (2.61%)
At close: Apr 28, 2026
Dx & Vx Revenue
In the year 2025, Dx & Vx had annual revenue of 29.36B KRW, down -13.52%. Dx & Vx had revenue of 7.55B in the quarter ending December 31, 2025, a decrease of -1.46%.
Revenue
29.36B
Revenue Growth
-13.52%
P/S Ratio
15.84
Revenue / Employee
n/a
Employees
n/a
Market Cap
465.08B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 3billion | 11.71B |
| GENINUS | 10.48B |
| Cytogen | 26.05B |
| HLB Panagene | 15.05B |
| Green Cross Medical Science | 108.41B |
| Protia | 15.12B |
| Seoulin Bioscience | 77.09B |
| GeneMatrix | 4.72B |